input stringlengths 30 8.71k | output unknown | schema unknown |
|---|---|---|
Down-regulation of interferon regulatory factor 4 gene expression in leukemic cells due to hypermethylation of CpG motifs in the promoter region
Although the bcr-abl translocation has been shown to be the causative genetic aberration in chronic myeloid leukemia (CML), there is mounting evidence that the deregulation o... | {
"entities": {
"protein": [
{
"text": "interferon regulatory factor 4",
"start": 19,
"end": 49
},
{
"text": "bcr",
"start": 159,
"end": 162
},
{
"text": "abl",
"start": 163,
"end": 166
},
{
"... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
INTRODUCTION
Chronic myeloid leukemia (CML) is a clonal myeloproliferative disorder with a typical three phased course (chronic, accelerated and blastic phase) reflecting the loss of differentiation and malignant progress which inevitably leads to death after the blastic phase (1,2). The hallmark genetic aberration of ... | {
"entities": {
"protein": [
{
"text": "bcr-abl fusion gene",
"start": 401,
"end": 420
},
{
"text": "interferon alpha",
"start": 480,
"end": 496
},
{
"text": "IFN-alpha",
"start": 498,
"end": 507
},
{... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Cell lines
K-562, Jurkat and U-937 were obtained from the ATCC (American Type Culture Collection, Rockville, USA) and EM-2, LAMA-84, CML-T1, BV-173, SD-1 and RPMI-8226 from the DSMZ (Deutsche Sammlung von Mikroorganismen und Zellkulturen GmbH, Braunschweig, Germany). All cell lines, except BV-173, SD-1 and RPMI-8226, w... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 324,
"end": 329
}
]
},
"json_structures": {
"gene expression": [
{
"trigger": {
"text": "negative",
"start": 330,
"end": 338
},
"arguments": [
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Cell culture and stimulation
All cell lines were maintained at 5% CO2 in RPMI 1640 medium with 1% glutamine (Gibco/BRL Eggenstein, Germany) supplemented with 10% fetal calf serum (Gibco/BRL), 1% penicillin/streptomycin (Biochrom, Berlin, Germany). When indicated, cells were treated with 5-aza-2-deoxycytidine (AzadC) or... | {
"entities": {},
"json_structures": {}
} | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Sequencing of the IRF-4 promoter
For analysis of the IRF-4 promoter region for permanent aberrations such as insertions/deletions or mutation, we PCR-amplified two fragments from genomic DNA, which was extracted from depicted cell lines with a commercial kit (Qiagen, Hilde, Germany) as recommended. The primers were 1-f... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 18,
"end": 23
},
{
"text": "IRF-4",
"start": 53,
"end": 58
}
]
},
"json_structures": {}
} | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Expression analysis
To analyze the IRF-4 transcriptional level, RNA was extracted from cells using the commercial RNAzol-kit (Paesel, Frankfurt, Germany). An aliquot of 1 mug total RNA was used for cDNA synthesis as described previously (27). RNA expression analysis for IRF-4 and the reference gene beta-actin was carri... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 35,
"end": 40
},
{
"text": "IRF-4",
"start": 271,
"end": 276
},
{
"text": "beta-actin",
"start": 300,
"end": 310
},
{
"text": "(DNMT1",... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Methylation-specific restriction-PCR-assay
DNA was extracted with a commercial kit (Qiagen) as recommended. Since the restriction ability of several endonucleases is inhibited by methylation of their target sequence, we used methylation-sensitive enzymes HpaII and HaeII-isochizomer Bsp143II and Bsh1236I (MBI Fermentas,... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 726,
"end": 731
}
]
},
"json_structures": {}
} | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Bisulfite treatment
DNA was extracted as described above. Bisulfite treatment of DNA, leading to conversion of unmethylated cytosine to uracil residues and no change of methylated cytosine residues, was performed as described as follows. Briefly, 1 microg of DNA and 2 microg of poly(dA-dT)(poly(dA-dT) copolymers (Amers... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 1171,
"end": 1176
}
]
},
"json_structures": {}
} | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
In vitro methylation and reporter gene assays
The IRF-4 promoter-reporter gene construct was generously provided by J.Hiscott (31). Constructs were methylated in vitro with CpG Methylase (M.Sss I) as recommended by the manufacturer (NE Biolabs) and complete methylation was checked via restriction analysis (Figure 5A). ... | {
"entities": {
"entity": [
{
"text": "promoter",
"start": 826,
"end": 834
}
],
"protein": [
{
"text": "IRF-4",
"start": 50,
"end": 55
},
{
"text": "CpG Methylase",
"start": 173,
"end": 186
},
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Absence of IRF-4 expression in leukemia cells is not due to promoter alterations
We have previously demonstrated a lack of IRF-4 expression in leukemia patients and specifically in CML T-cells (3). Here, we demonstrate the absence of IRF-4 expression in various hematopoietic cell lines, such as Jurkat, a T-cell leukemi... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 11,
"end": 16
},
{
"text": "IRF-4",
"start": 123,
"end": 128
},
{
"text": "IRF-4",
"start": 234,
"end": 239
},
{
"text": "bcr-abl",
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Increase of IRF-4 expression in hematopoietic cells after demethylating treatment
We next analyzed whether promoter methylation could be responsible for down-regulation of IRF-4 expression. A region including exon1 in the IRF-4 promoter exhibited a large number of CpG-rich sequences (Figure 3A). Several chemical substa... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 12,
"end": 17
},
{
"text": "IRF-4",
"start": 172,
"end": 177
},
{
"text": "IRF-4",
"start": 222,
"end": 227
},
{
"text": "IRF-4",
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Methylation-sensitive enzymes do not cut specific sites in the IRF-4 promoter in hematopoietic cells
To further investigate promoter methylation as a regulatory mechanism of IRF-4 gene expression, restriction-PCR-assays were performed (20,24), where only methylated DNA would not be cut enabling subsequent PCR amplifica... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 63,
"end": 68
},
{
"text": "IRF-4",
"start": 174,
"end": 179
},
{
"text": "IRF-4",
"start": 567,
"end": 572
},
{
"text": "IRF-4",
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Specific CpG sites in the IRF-4 promoter are methylated in hematopoietic cells
In order to exactly map the methylation sites within the IRF-4 promoter, we treated DNA of Jurkat, CML-T1, U-937, K-562 and EM-2 cells as well as of SD-1, RPMI-8226 and BV-173 control cells with bisulfite, which chemically converts unmethyla... | {
"entities": {
"protein": [
{
"text": "IRF-4",
"start": 26,
"end": 31
},
{
"text": "IRF-4",
"start": 136,
"end": 141
},
{
"text": "IRF-4",
"start": 766,
"end": 771
},
{
"text": "IRF-4",
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
In vitro methylation of an IRF-4 promoter-reporter construct decreases its activity
To provide evidence for a direct effect of methylational status on IRF-4 promoter activity we performed reporter gene assays with IRF-4 promoter constructs before and after their in vitro methylation. A complete methylation of these con... | {
"entities": {
"entity": [
{
"text": "promoter",
"start": 489,
"end": 497
},
{
"text": "promoter",
"start": 698,
"end": 706
}
],
"protein": [
{
"text": "IRF-4",
"start": 27,
"end": 32
},
{
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
mRNA expression of DNA methyltransferases and methyl-CpG-binding proteins may not be associated with IRF-4 promoter methylation
Since abundance of DNMT and MBP contribute to promoter regulation via methylation (25,26,28), we studied their mRNA expression to investigate a possible mechanism for the observed methylation ... | {
"entities": {
"entity": [
{
"text": "promoter",
"start": 174,
"end": 182
}
],
"protein": [
{
"text": "IRF-4",
"start": 101,
"end": 106
},
{
"text": "IRF-4",
"start": 339,
"end": 344
},
{
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
DISCUSSION
Many genetic lesions are known to influence gene expression of tumor suppressor genes. Whereas mutations and deletions or insertions have permanent effects, reversible mechanisms are gene methylation, or expression and activation of transcription factors, respectively. We studied a putative cause for absent ... | {
"entities": {
"entity": [
{
"text": "transcription factor binding sites",
"start": 999,
"end": 1033
},
{
"text": "restriction sites",
"start": 1069,
"end": 1086
},
{
"text": "primer binding sites",
"start": 1090,
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Foxp3 Represses Retroviral Transcription by Targeting Both NF-kappaB and CREB Pathways
Forkhead box (Fox)/winged-helix transcription factors regulate multiple aspects of immune responsiveness and Foxp3 is recognized as an essential functional marker of regulatory T cells. Herein we describe downstream signaling pathwa... | {
"entities": {
"entity": [
{
"text": "carboxyl-terminal forkhead (FKH) domain",
"start": 593,
"end": 632
},
{
"text": "nuclear",
"start": 647,
"end": 654
}
],
"protein": [
{
"text": "Foxp3",
"start": 0,
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Synopsis
Over the past several years, mounting evidence has shown that immune tolerance in healthy individuals can be maintained by a population of T lymphocytes known as regulatory T cells (Tregs). As a component of this system, a protein known as Foxp3 has been shown to be absolutely required for the development and ... | {
"entities": {
"protein": [
{
"text": "Foxp3",
"start": 249,
"end": 254
},
{
"text": "Foxp3",
"start": 345,
"end": 350
},
{
"text": "Foxp3",
"start": 564,
"end": 569
},
{
"text": "Foxp3",
... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Introduction
Immunological tolerance to self-antigens is the result of the deletion of self-reactive T lymphocytes in the thymus (central tolerance) and suppression of the activation of potentially self-reactive T lymphocytes in the periphery (peripheral tolerance) [1]. Suppression of pathogenic T cell responses is med... | {
"entities": {
"entity": [
{
"text": "leucine zipper",
"start": 1478,
"end": 1492
},
{
"text": "carboxyl-terminal forkhead (FKH) domain",
"start": 1555,
"end": 1594
},
{
"text": "nuclear",
"start": 1608,
"end": ... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
Foxp3 Suppresses NF-kappaB Dependent Transcriptional Activation
To ascertain the molecular mechanisms by which Foxp3 functions to promote the regulatory function of CD4+CD25hi T cells, we first confirmed the function of Foxp3 as a repressor of activation of NF-kappaB, previously implicated as a target of other forkhead... | {
"entities": {
"protein": [
{
"text": "Foxp3",
"start": 0,
"end": 5
},
{
"text": "Foxp3",
"start": 111,
"end": 116
},
{
"text": "CD4",
"start": 165,
"end": 168
},
{
"text": "CD25",
"s... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
The Carboxyl-Terminal FKH Domain Is Not Required for Suppression of NF-kappaB Activation in T Cells
To define the requirements of Foxp3 with respect to inhibition of NF-kappaB-dependent transcription, we utilized a mutant of Foxp3 lacking the FKH domain (Figure 2A) [16], similar to the scurfy mutant Foxp3 of mice, and ... | {
"entities": {
"entity": [
{
"text": "FKH domain",
"start": 243,
"end": 253
},
{
"text": "nucleus",
"start": 450,
"end": 457
},
{
"text": "nucleus",
"start": 573,
"end": 580
},
{
"text": "nuc... | {
"entities": [
{
"label": "entity",
"description": "A generic non-protein physical entity used as an event site or location argument."
},
{
"label": "protein",
"description": "A gene or gene-product mention, represented by the GENIA Protein label."
}
],
"json_structures": ... |
GENIA 2011 (mneb format) — joint NER + nested event extraction
The BioNLP Shared Task 2011 GE corpus (Kim et al., 2011) converted into the mneb
joint entities + json_structures format. GENIA is a biomedical entity and end-to-end
event extraction dataset over PubMed abstracts and PMC full texts.
This dataset keeps event-as-argument nesting. Roughly a third of GENIA's argument links
point at another event rather than an entity — regulation events take other events as their
Theme or Cause — and prior conversions (including TextEE's) drop them. Here they are kept
without leaving the flat mneb record shape: every argument is a plain
{role,text,start,end} span, and an argument that points at an event carries that event's
trigger span. See Event arguments.
Char offsets are character-based and end-exclusive (input[start:end] == text).
One record = one source .txt file (PMC full-text sections are not merged into papers).
Splits
| Split | Records | With events | Events |
|---|---|---|---|
| train | 908 | 765 | 9,560 |
| validation | 259 | 225 | 2,988 |
| Total | 1,167 | 990 | 12,548 |
There is no labelled test split. The official blind-test archive contains 347 .txt/.a1
inputs, but BioNLP-ST did not publicly release their .a2 event gold. This release therefore
contains the official train/devel partition only; treating the blind inputs as empty output
would create false negatives. Note that this differs from TextEE, which discards the official
boundary and makes five random re-splits instead — no number reported on a TextEE split is
directly comparable to this one.
Supported tasks and retained layers
- NER:
proteinand genericentitymentions inoutput.entities. - Event detection (ED): event triggers in
output.json_structures. - Event argument extraction (EAE) and end-to-end event extraction (E2E): trigger and argument spans, including span-linked event arguments.
- Joint NER + EE: both layers occur in the same record and use the same character offsets.
Equivalence, event attributes and normalisations are not exposed, so this release does not claim relation extraction, coreference, negation or speculation as supported tasks.
Entity layer — 2 types, 16,976 mentions
| Entity type | Train | Validation | Total |
|---|---|---|---|
| entity | 480 | 181 | 661 |
| protein | 11,625 | 4,690 | 16,315 |
| Total | 12,105 | 4,871 | 16,976 |
protein is the public form of .a1 label Protein; entity is the public form of the
generic .a2 label Entity used for non-protein physical participants, sites and locations.
The names are uniformly lower-case with spaces, matching mneb's public entity-label policy.
Record format
{
"input": "<document text>",
"output": {
"entities": {"protein": [<span>, ...], "entity": [<span>, ...]},
"json_structures": {"<event type>": [<event>, ...]}
},
"schema": {"entities": [<entity definition>, ...],
"json_structures": [<event definition>, ...]}
}
The active data/train.jsonl and data/validation.jsonl use lower-case, space-separated
event labels (for example gene expression), preserving the convention introduced by
yangwang825. Compatibility files prefixed genia2011_ retain the official event strings
(for example Gene_expression). NER labels are normalized in both views.
An event is {"trigger": {"text","start","end"}, "arguments": [<arg>, ...]}. There is
nothing else: no type field on the event (its type is the json_structures key), and no
object nested inside an argument.
Event arguments
Every argument has the same four keys, whether it points at an entity or at another event:
{"role": "Theme", "text": "interferon regulatory factor 4", "start": 19, "end": 49}
{"role": "Theme", "text": "expression", "start": 55, "end": 65}
The first is an entity mention. The second is an event link: (55, 65) is the trigger span
of a gene expression event, which is listed at the top level of the same record. This is how
mneb expresses links generally — repeat the span, no ids (cf. mneb/bc5cdr, whose relation
head/tail repeat the entity spans).
Because a linked child must be reachable, every event appears at the top level, not only the roots. To resolve links:
def resolve(js):
"""Index every event by its trigger span, then read arguments as links where they match."""
by_span = {}
for etype, evs in js.items():
for ev in evs:
by_span.setdefault((ev["trigger"]["start"], ev["trigger"]["end"]), []).append((etype, ev))
for etype, evs in js.items():
for ev in evs:
for a in ev["arguments"]:
target = by_span.get((a["start"], a["end"])) # None => entity mention
yield etype, ev, a, target
A real example — "Down-regulation of interferon regulatory factor 4 gene expression…". Two
top-level events; the Theme link Down-regulation → expression is the nesting:
"negative regulation": [{
"trigger": {"text": "Down-regulation", "start": 0, "end": 15},
"arguments": [{"role": "Theme", "text": "expression", "start": 55, "end": 65}]}],
"gene expression": [{
"trigger": {"text": "expression", "start": 55, "end": 65},
"arguments": [{"role": "Theme", "text": "interferon regulatory factor 4",
"start": 19, "end": 49}]}]
How faithful the span links are
- Telling a link from an entity mention: just 1 of the 11,590 entity-valued arguments sits on a span that is also a trigger, so the test "this argument's span matches a trigger span" has a single false positive corpus-wide.
- Telling which event a link points at: 3,860 of the 5,502 links (70.2%) match exactly one event of the right type. The other 1,642 (29.8%) land on a trigger span shared by several same-type events, and the span cannot disambiguate them — GENIA 2011 is the worst of the three BioNLP corpora here, because one regulation trigger routinely heads several events.
- Consequently 1,012 of the 13,560 raw
Elines (7.5%) come out byte-identical to another entry of the same type and are collapsed, leaving 12,548 events. Those are exactly the parents that differed only in an unresolvable choice of child; keeping both copies would double-count in any set-based metric.
Everything else round-trips: the offset invariant holds on every span, and the set of emitted
(type, trigger, role/span) signatures equals the same set computed straight off the raw
standoff, for every document.
Statistics
- 9 event types, 10 role types (role strings kept verbatim, so
Theme2/Theme3/Theme4/Site2are not collapsed into their base role). - 17,092 raw argument links = 11,590 entity-valued + 5,502 event-valued (32.2% of all argument links are event-to-event). After the collapse above the files hold 15,652 argument instances = 11,354 entity spans + 4,298 span links.
- 4,964 events (36.6%) take at least one event argument.
- Raw nesting depth histogram
{1: 8596, 2: 4209, 3: 710, 4: 44, 5: 1}— max depth 5. - Nesting is driven entirely by the three regulation types; no other event type ever takes an
event argument, and only
ThemeandCauseare ever event-linked.
Full type/role inventory and nesting patterns: genia2011_label_summary.md.
Browsable rendering: genia2011_vis.html (open directly; data embedded, no server needed).
How this was derived
Required by clause 5 of the source licence. Built from the official
BioNLP-ST_2011_genia_train_data_rev1 and ..._devel_data_rev1 archives:
- Each document's
.a1(Protein entities) and.a2(event triggers,Entityspans andEevent lines) are parsed into a single text-bound annotation map; their id spaces do not collide. ProteinandEntityannotations become NER mentions under normalized public labels.- Each
Eline becomes an event grouped under its own type;Role:T…arguments become the entity's span andRole:E…arguments become the child event's trigger span. Both come out in the same{role,text,start,end}shape. - Every event is listed at the top level, so a linked child is always resolvable. Entries that are byte-identical under one event type are then collapsed.
- Equivalence (
*), attribute (A/M: Negation, Speculation) and normalisation (N) lines are not carried over. The converter and compatibility files preserve official event-type strings; the active files normalize only event-type labels. Roles remain verbatim in both views.
The raw standoff gives labels but no prose label descriptions. The descriptions embedded in
the full schema and published in schema.json are concise mneb-authored paraphrases based on
the official task definition and paper; they are not source annotations or quotations.
Verification built into the converter: every emitted span is re-checked against the source
text (input[start:end] == text, 0 failures); the set of emitted (type, trigger, role/span)
signatures is compared against the same set computed straight off the raw standoff and is equal
for every document; and a link audit reports, for every event-valued argument, whether its
child is uniquely identifiable from the span (the numbers quoted above).
Licence and terms of use
Distributed under the BioNLP Shared Task 2011 licence terms, which permit redistribution with these conditions:
- Research use. The annotations are to be used primarily for scholarly research in NLP, IE and related disciplines. Derived data may be produced only for bona fide research of a non-profit nature.
- Commercial or non-academic public use requires permission from the BioNLP-ST'11 organisers.
- Abstracts come from PubMed® (U.S. National Library of Medicine) and are subject to the PubMed licence terms. Full texts come from the PMC Open Access Subset; each article carries its own Creative Commons or similar licence.
- Copyright in the annotations belongs to the BioNLP-ST'11 organisers.
Please read the full terms at the source link above before redistributing or building on this data.
Citation
@inproceedings{Kim11genia2011,
author = {Jin-Dong Kim and Yue Wang and Toshihisa Takagi and Akinori Yonezawa},
title = {Overview of Genia Event Task in BioNLP Shared Task 2011},
booktitle = {Proceedings of BioNLP Shared Task 2011 Workshop},
year = {2011}
}
- Downloads last month
- 87